Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris McGuigan

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Practical Neurology|October 29, 2025
Radiologically isolated syndrome: a practical guideAudrey Reynolds, Rory O'Donohoe, Chris McGuigan
Free Radical Research|July 23, 2005
Topical delivery of retinyl ascorbate: 4. Comparative anti-oxidant activity towards DPPHKasem Abdulmajed, Chris McGuigan, Charles M Heard
Pharmaceutical Research|June 24, 2004
In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skinChris A Jarvis, Chris McGuigan, Charles M Heard
Journal of Drug Targeting|June 19, 2004
Targeted dermal delivery of highly potent anti-varicella zoster virus nucleoside analogues from saturated solutions and ethanolic oil-in-water creamsChris A Jarvis, Charles M Heard, Chris McGuigan
Irish Journal of Medical Science|October 27, 2020
Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease durationNuala McNicholas, Niall Tubridy, Michael Hutchinson, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2017
Kinase-independent phosphoramidate S1P<sub>1</sub> receptor agonist benzyl ether derivativesEdward James, Fabrizio Pertusati, Andrea Brancale, et al.
Clinical Rehabilitation|August 15, 2018
Discriminative ability and clinical utility of the Timed Up and Go (TUG) in identifying falls risk in people with multiple sclerosis: a prospective cohort studyGillian Quinn, Laura Comber, Chris McGuigan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2017
Medication usage and falls in people with multiple sclerosisLaura Comber, Gillian Quinn, Chris McGuigan, et al.
Clinical Rehabilitation|December 16, 2020
Risk factors for falling for people with Multiple Sclerosis identified in a prospective cohort studyGillian Quinn, Laura Comber, Chris McGuigan, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosidesGraciela Andrei, Rebecca Sienaert, Chris McGuigan, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Practical Neurology|October 29, 2025
Radiologically isolated syndrome: a practical guideAudrey Reynolds, Rory O'Donohoe, Chris McGuigan
Free Radical Research|July 23, 2005
Topical delivery of retinyl ascorbate: 4. Comparative anti-oxidant activity towards DPPHKasem Abdulmajed, Chris McGuigan, Charles M Heard
Pharmaceutical Research|June 24, 2004
In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skinChris A Jarvis, Chris McGuigan, Charles M Heard
Journal of Drug Targeting|June 19, 2004
Targeted dermal delivery of highly potent anti-varicella zoster virus nucleoside analogues from saturated solutions and ethanolic oil-in-water creamsChris A Jarvis, Charles M Heard, Chris McGuigan
Irish Journal of Medical Science|October 27, 2020
Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease durationNuala McNicholas, Niall Tubridy, Michael Hutchinson, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2017
Kinase-independent phosphoramidate S1P<sub>1</sub> receptor agonist benzyl ether derivativesEdward James, Fabrizio Pertusati, Andrea Brancale, et al.
Clinical Rehabilitation|August 15, 2018
Discriminative ability and clinical utility of the Timed Up and Go (TUG) in identifying falls risk in people with multiple sclerosis: a prospective cohort studyGillian Quinn, Laura Comber, Chris McGuigan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2017
Medication usage and falls in people with multiple sclerosisLaura Comber, Gillian Quinn, Chris McGuigan, et al.
Clinical Rehabilitation|December 16, 2020
Risk factors for falling for people with Multiple Sclerosis identified in a prospective cohort studyGillian Quinn, Laura Comber, Chris McGuigan, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosidesGraciela Andrei, Rebecca Sienaert, Chris McGuigan, et al.
Pageof 4